Sanofi is investing about $550 million in a vaccine manufacturing facility in Neuville sur Saone, France, with support from the French government.

The facility will be capable of manufacturing three to four vaccines simultaneously, enabling the company to tailor production in response to public health needs, the drugmaker says. Source: Biopharma DIve 16/6/2020